<p>TransMedics Group, Inc.（納斯達克代碼：TMDX - 獲取免費報告）週一股價上漲了 7.1%。該公司股價最高達到 68.38 美元，最後交易價格為 67.7150 美元。在午盤交易中，共交易了 214,221 股，較平均交易量 1,057,757 股下降了 80%。該股票此前收盤價為 63.20 美元。</p>
<p>獲取 <strong>TransMedics Group</strong> 的提醒：</p>
<h2>華爾街分析師觀點</h2>
<ul>
<li>中型股奇蹟：三隻在 5 月超越銷售預期的股票</li>
</ul>
<p>多家研究公司已對 TMDX 發佈了報告。Canaccord Genuity Group 將 TransMedics Group 的目標價從 152.00 美元下調至 124.00 美元，並在 5 月 6 日的報告中給予該股票 “買入” 評級。TD Cowen 將 TransMedics Group 的目標價從 190.00 美元下調至 120.00 美元，並在 5 月 6 日的研究報告中給予該股票 “買入” 評級。Stifel Nicolaus 將 TransMedics Group 的目標價從 130.00 美元下調至 85.00 美元，並在 5 月 6 日的研究報告中給予該股票 “持有” 評級。Needham &amp; Company LLC 將 TransMedics Group 的目標價從 174.00 美元下調至 142.00 美元，並在 5 月 6 日的報告中給予該公司 “買入” 評級。最後，Wall Street Zen 在 5 月 9 日的研究報告中將 TransMedics Group 的評級從 “持有” 下調至 “賣出”。六位投資分析師對該股票給予了 “買入” 評級，六位分析師給予了 “持有” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 135.00 美元。</p>
<p><strong>查看我們對 TMDX 的最新分析</strong></p>
<h2>TransMedics Group 股票表現</h2>
<ul>
<li>三隻在 2025 年表現優異的醫療科技股票</li>
</ul>
<p>該股票的 50 日簡單移動平均線為 104.66 美元，200 日簡單移動平均線為 122.77 美元。該公司的市值為 23.3 億美元，市盈率為 15.33，貝塔值為 2.07。該公司的債務與股本比率為 1.70，速動比率為 6.19，流動比率為 6.74。</p>
<p>TransMedics Group（納斯達克代碼：TMDX - 獲取免費報告）最近於 5 月 5 日發佈了其財報。該公司報告季度每股收益為 0.30 美元，低於分析師一致預期的 0.62 美元，差距為 0.32 美元。TransMedics Group 的股本回報率為 22.38%，淨利潤率為 27.04%。該公司季度收入為 1.7393 億美元，而分析師預期為 1.7444 億美元。在去年同期，該公司每股收益為 0.70 美元。該公司的季度收入同比增長 21.2%。整體來看，研究分析師預計 TransMedics Group, Inc.在當前財年將發佈 1.98 美元的每股收益。</p>
<h2>內部人士下注</h2>
<ul>
<li>三隻高增長股票，交易者喜愛，投資者應關注</li>
</ul>
<p>在相關消息中，內部人士 Anil P. Ranganath 於 3 月 2 日星期一出售了 864 股公司的股票，交易價格為 139.12 美元，總價值為 120,199.68 美元。交易完成後，該內部人士直接持有 13,091 股公司股票，價值為 1,821,219.92 美元。這代表其持股比例下降了 6.19%。該交易已在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。此外，首席財務官 Gerardo Hernandez 於 3 月 4 日星期三出售了 7,236 股股票，交易價格為 147.21 美元，總交易額為 1,065,211.56 美元。交易完成後，首席財務官持有 14,689 股公司股票，價值為 2,162,367.69 美元。這代表其持股比例下降了 33.00%。該交易的披露信息可在 SEC 文件中找到。在上個季度，內部人士共出售了價值 2,353,002 美元的 16,205 股公司股票。目前，內部人士持有該公司 6.90% 的股票。</p>
<h2>對 TransMedics Group 的對沖基金觀點</h2>
<p>幾家大型投資者最近買入和賣出了 TMDX 的股票。Quantinno Capital Management LP 在第一季度將其在 TransMedics Group 的持股增加了 197.9%。Quantinno Capital Management LP 現在擁有 8,059 股公司股票，價值為 801,000 美元，此前在上個季度又購買了 5,354 股。Beaconlight Capital LLC 在第一季度將其在 TransMedics Group 的持股增加了 44.8%。Beaconlight Capital LLC 現在擁有 42,478 股公司股票，價值為 4,223,000 美元，此前在上個季度又購買了 13,134 股。俄亥俄州公共僱員退休系統在第一季度將其在 TransMedics Group 的持股增加了 8.1%。俄亥俄州公共僱員退休系統現在擁有 14,666 股公司股票，價值為 1,458,000 美元，此前在該期間又購買了 1,094 股。Keebeck Wealth Management 在第一季度將其在 TransMedics Group 的持股增加了 12.4%。Keebeck Wealth Management 現在擁有 5,175 股公司股票，價值為 514,000 美元，此前在上個季度又購買了 572 股。最後，Sei Investments Co.在第一季度將其在 TransMedics Group 的持股增加了 25.9%。Sei Investments Co.現在擁有 69,629 股公司股票，價值為 6,922,000 美元，此前在上個季度又購買了 14,338 股。機構投資者和對沖基金持有該公司 99.67% 的股票。</p>
<h2>TransMedics Group 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>TransMedics Group, Inc 是一家總部位於馬薩諸塞州安多佛的醫療設備公司，專注於先進的器官保存和運輸系統，以用於移植。該公司的旗艦技術——器官護理系統（OCS），在運輸過程中保持供體器官處於接近生理狀態的温暖跳動狀態，旨在延長保存時間並改善移植後的結果。TransMedics 的解決方案滿足了移植領域的關鍵需求，通過減少缺血損傷和擴大供體器官池來解決問題。</p>
<p>TransMedics 目前市場上有兩個可商業化的 OCS 平台。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們認為比 TransMedics Group 更好的股票</li>
<li>為什麼 Applied Optoelectronics 的股票可能接近轉折點</li>
<li>從高收益到高增長：3 只提升股息的股票</li>
<li>Everspin Technologies 會是下一個 AI 邊緣突破嗎？</li>
<li>5 只機器人股票值得關注，因為物理 AI 正在蓬勃發展</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 TransMedics Group 嗎？</h2>
<p>在考慮 TransMedics Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 TransMedics Group 並不在名單上。</p>
<p>雖然 TransMedics Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

TMDX

標普健康醫療設備 ETF - SPDR

醫藥突破 ETF - ALPS

美國醫藥設備 ETF - iShares

<p>TransMedics Group（納斯達克代碼：TMDX）股價上漲 7.1%，至 67.71 美元，儘管交易量顯著下降。分析師的評級不一，目標價格範圍從 85 美元到 190 美元不等。該公司報告第一季度每股收益為 0.30 美元，低於預期，但收入同比增長 21.2%。內部人士最近出售了股份，而對沖基金則增加了對該公司的持股</p>

<p>Shares of TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) traded up 7.1% on Monday . The company traded as high as $68.38 and last traded at $67.7150. 214,221 shares were traded during mid-day trading, a decline of 80% from the average session volume of 1,057,757 shares. The stock had previously closed at $63.20.</p>
<div class="lb-trans"><p>TransMedics Group, Inc.（納斯達克代碼：TMDX - 獲取免費報告）週一股價上漲了 7.1%。該公司股價最高達到 68.38 美元，最後交易價格為 67.7150 美元。在午盤交易中，共交易了 214,221 股，較平均交易量 1,057,757 股下降了 80%。該股票此前收盤價為 63.20 美元。</p>
</div><p>Get <strong>TransMedics Group</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>TransMedics Group</strong> 的提醒：</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><ul>
<li>Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May</li>
</ul>
<div class="lb-trans"><ul>
<li>中型股奇蹟：三隻在 5 月超越銷售預期的股票</li>
</ul>
</div><p>A number of research firms have issued reports on TMDX. Canaccord Genuity Group reduced their target price on shares of TransMedics Group from $152.00 to $124.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, May 6th. TD Cowen cut their price objective on TransMedics Group from $190.00 to $120.00 and set a &#34;buy&#34; rating on the stock in a research report on Wednesday, May 6th. Stifel Nicolaus reduced their price objective on TransMedics Group from $130.00 to $85.00 and set a &#34;hold&#34; rating on the stock in a research note on Wednesday, May 6th. Needham &amp; Company LLC decreased their target price on TransMedics Group from $174.00 to $142.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, May 6th. Finally, Wall Street Zen cut TransMedics Group from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, May 9th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $135.00.</p>
<div class="lb-trans"><p>多家研究公司已對 TMDX 發佈了報告。Canaccord Genuity Group 將 TransMedics Group 的目標價從 152.00 美元下調至 124.00 美元，並在 5 月 6 日的報告中給予該股票 “買入” 評級。TD Cowen 將 TransMedics Group 的目標價從 190.00 美元下調至 120.00 美元，並在 5 月 6 日的研究報告中給予該股票 “買入” 評級。Stifel Nicolaus 將 TransMedics Group 的目標價從 130.00 美元下調至 85.00 美元，並在 5 月 6 日的研究報告中給予該股票 “持有” 評級。Needham &amp; Company LLC 將 TransMedics Group 的目標價從 174.00 美元下調至 142.00 美元，並在 5 月 6 日的報告中給予該公司 “買入” 評級。最後，Wall Street Zen 在 5 月 9 日的研究報告中將 TransMedics Group 的評級從 “持有” 下調至 “賣出”。六位投資分析師對該股票給予了 “買入” 評級，六位分析師給予了 “持有” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 135.00 美元。</p>
</div><p><strong>View Our Latest Analysis on TMDX</strong></p>
<div class="lb-trans"><p><strong>查看我們對 TMDX 的最新分析</strong></p>
</div><h2>TransMedics Group Stock Performance</h2>
<div class="lb-trans"><h2>TransMedics Group 股票表現</h2>
</div><ul>
<li>3 Medical Technology Stocks Outperforming in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>三隻在 2025 年表現優異的醫療科技股票</li>
</ul>
</div><p>The stock's 50-day simple moving average is $104.66 and its 200 day simple moving average is $122.77. The company has a market capitalization of $2.33 billion, a PE ratio of 15.33 and a beta of 2.07. The company has a debt-to-equity ratio of 1.70, a quick ratio of 6.19 and a current ratio of 6.74.</p>
<div class="lb-trans"><p>該股票的 50 日簡單移動平均線為 104.66 美元，200 日簡單移動平均線為 122.77 美元。該公司的市值為 23.3 億美元，市盈率為 15.33，貝塔值為 2.07。該公司的債務與股本比率為 1.70，速動比率為 6.19，流動比率為 6.74。</p>
</div><p>TransMedics Group (NASDAQ:TMDX - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.30 EPS for the quarter, missing analysts' consensus estimates of $0.62 by ($0.32). TransMedics Group had a return on equity of 22.38% and a net margin of 27.04%.The firm had revenue of $173.93 million for the quarter, compared to analyst estimates of $174.44 million. During the same quarter in the previous year, the firm posted $0.70 EPS. The business's revenue for the quarter was up 21.2% on a year-over-year basis. As a group, research analysts expect that TransMedics Group, Inc. will post 1.98 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>TransMedics Group（納斯達克代碼：TMDX - 獲取免費報告）最近於 5 月 5 日發佈了其財報。該公司報告季度每股收益為 0.30 美元，低於分析師一致預期的 0.62 美元，差距為 0.32 美元。TransMedics Group 的股本回報率為 22.38%，淨利潤率為 27.04%。該公司季度收入為 1.7393 億美元，而分析師預期為 1.7444 億美元。在去年同期，該公司每股收益為 0.70 美元。該公司的季度收入同比增長 21.2%。整體來看，研究分析師預計 TransMedics Group, Inc.在當前財年將發佈 1.98 美元的每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><ul>
<li>3 High-Growth Stocks Traders Love and Investors Should Watch</li>
</ul>
<div class="lb-trans"><ul>
<li>三隻高增長股票，交易者喜愛，投資者應關注</li>
</ul>
</div><p>In related news, insider Anil P. Ranganath sold 864 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $139.12, for a total value of $120,199.68. Following the completion of the transaction, the insider directly owned 13,091 shares of the company's stock, valued at $1,821,219.92. This represents a 6.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Gerardo Hernandez sold 7,236 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $147.21, for a total transaction of $1,065,211.56. Following the completion of the transaction, the chief financial officer owned 14,689 shares in the company, valued at $2,162,367.69. This represents a 33.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 16,205 shares of company stock worth $2,353,002. 6.90% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相關消息中，內部人士 Anil P. Ranganath 於 3 月 2 日星期一出售了 864 股公司的股票，交易價格為 139.12 美元，總價值為 120,199.68 美元。交易完成後，該內部人士直接持有 13,091 股公司股票，價值為 1,821,219.92 美元。這代表其持股比例下降了 6.19%。該交易已在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。此外，首席財務官 Gerardo Hernandez 於 3 月 4 日星期三出售了 7,236 股股票，交易價格為 147.21 美元，總交易額為 1,065,211.56 美元。交易完成後，首席財務官持有 14,689 股公司股票，價值為 2,162,367.69 美元。這代表其持股比例下降了 33.00%。該交易的披露信息可在 SEC 文件中找到。在上個季度，內部人士共出售了價值 2,353,002 美元的 16,205 股公司股票。目前，內部人士持有該公司 6.90% 的股票。</p>
</div><h2>Hedge Funds Weigh In On TransMedics Group</h2>
<div class="lb-trans"><h2>對 TransMedics Group 的對沖基金觀點</h2>
</div><p>Several large investors have recently bought and sold shares of TMDX. Quantinno Capital Management LP grew its holdings in shares of TransMedics Group by 197.9% during the first quarter. Quantinno Capital Management LP now owns 8,059 shares of the company's stock worth $801,000 after purchasing an additional 5,354 shares during the last quarter. Beaconlight Capital LLC lifted its holdings in shares of TransMedics Group by 44.8% in the 1st quarter. Beaconlight Capital LLC now owns 42,478 shares of the company's stock valued at $4,223,000 after purchasing an additional 13,134 shares during the last quarter. Public Employees Retirement System of Ohio boosted its position in shares of TransMedics Group by 8.1% in the 1st quarter. Public Employees Retirement System of Ohio now owns 14,666 shares of the company's stock valued at $1,458,000 after purchasing an additional 1,094 shares during the period. Keebeck Wealth Management grew its stake in TransMedics Group by 12.4% during the 1st quarter. Keebeck Wealth Management now owns 5,175 shares of the company's stock worth $514,000 after buying an additional 572 shares during the last quarter. Finally, Sei Investments Co. grew its stake in TransMedics Group by 25.9% during the 1st quarter. Sei Investments Co. now owns 69,629 shares of the company's stock worth $6,922,000 after buying an additional 14,338 shares during the last quarter. Institutional investors and hedge funds own 99.67% of the company's stock.</p>
<div class="lb-trans"><p>幾家大型投資者最近買入和賣出了 TMDX 的股票。Quantinno Capital Management LP 在第一季度將其在 TransMedics Group 的持股增加了 197.9%。Quantinno Capital Management LP 現在擁有 8,059 股公司股票，價值為 801,000 美元，此前在上個季度又購買了 5,354 股。Beaconlight Capital LLC 在第一季度將其在 TransMedics Group 的持股增加了 44.8%。Beaconlight Capital LLC 現在擁有 42,478 股公司股票，價值為 4,223,000 美元，此前在上個季度又購買了 13,134 股。俄亥俄州公共僱員退休系統在第一季度將其在 TransMedics Group 的持股增加了 8.1%。俄亥俄州公共僱員退休系統現在擁有 14,666 股公司股票，價值為 1,458,000 美元，此前在該期間又購買了 1,094 股。Keebeck Wealth Management 在第一季度將其在 TransMedics Group 的持股增加了 12.4%。Keebeck Wealth Management 現在擁有 5,175 股公司股票，價值為 514,000 美元，此前在上個季度又購買了 572 股。最後，Sei Investments Co.在第一季度將其在 TransMedics Group 的持股增加了 25.9%。Sei Investments Co.現在擁有 69,629 股公司股票，價值為 6,922,000 美元，此前在上個季度又購買了 14,338 股。機構投資者和對沖基金持有該公司 99.67% 的股票。</p>
</div><h2>TransMedics Group Company Profile</h2>
<div class="lb-trans"><h2>TransMedics Group 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>TransMedics Group, Inc is a medical device company headquartered in Andover, Massachusetts, that specializes in advanced organ preservation and transport systems for transplantation. The company's flagship technology, the Organ Care System (OCS), maintains donor organs in a near-physiologic, warm, beating state during transportation, with the aim of extending preservation times and improving post‐transplant outcomes. TransMedics' solutions address a critical need in transplantation by reducing ischemic injury and expanding the donor organ pool.</p>
<div class="lb-trans"><p>TransMedics Group, Inc 是一家總部位於馬薩諸塞州安多佛的醫療設備公司，專注於先進的器官保存和運輸系統，以用於移植。該公司的旗艦技術——器官護理系統（OCS），在運輸過程中保持供體器官處於接近生理狀態的温暖跳動狀態，旨在延長保存時間並改善移植後的結果。TransMedics 的解決方案滿足了移植領域的關鍵需求，通過減少缺血損傷和擴大供體器官池來解決問題。</p>
</div><p>TransMedics currently markets two commercially available OCS platforms.</p>
<div class="lb-trans"><p>TransMedics 目前市場上有兩個可商業化的 OCS 平台。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than TransMedics Group</li>
<li>Why Applied Optoelectronics Stock May Be Near a Turning Point</li>
<li>From High-Yield to High-Growth: 3 Stocks Boosting Dividends</li>
<li>Is Everspin Technologies the Next AI Edge Breakout?</li>
<li>5 Robotics Stocks to Watch as Physical AI Builds Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 TransMedics Group 更好的股票</li>
<li>為什麼 Applied Optoelectronics 的股票可能接近轉折點</li>
<li>從高收益到高增長：3 只提升股息的股票</li>
<li>Everspin Technologies 會是下一個 AI 邊緣突破嗎？</li>
<li>5 只機器人股票值得關注，因為物理 AI 正在蓬勃發展</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in TransMedics Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 TransMedics Group 嗎？</h2>
</div><p>Before you consider TransMedics Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 TransMedics Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TransMedics Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 TransMedics Group 並不在名單上。</p>
</div><p>While TransMedics Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 TransMedics Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

TransMedics Group（NASDAQ:TMDX）股價上漲 7.1% - 事情經過